Evidence map›Paper›PMID 39115799›Full record

ReviewCurrent cardiology reports2024

Chagas Disease: Epidemiology, Diagnosis, and Treatment.

Michael C Swett, Danny L Rayes, Silvia Vidal Campos, Rebecca N Kumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Anti-ACS omega · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Pathogens (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael C SwettDepartment of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.ORCID 0009-0000-2024-5521
Danny L RayesDepartment of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.ORCID 0000-0002-5656-5305
Silvia Vidal CamposPulmonary Division, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, SP, Brazil.ORCID 0000-0003-3297-5948
Rebecca N KumarDivision of Infectious Disease and Tropical Medicine, MedStar Georgetown University Hospital, Washington, DC, USA. rebecca.n.kumar@gunet.georgetown.edu.ORCID 0000-0001-6650-0612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review seeks to describe the updates in the literature - particularly with regards to the epidemiology and diagnosis of Chagas disease. Additionally, this paper describes updates to the antiparasitic treatment for Chagas disease. RECENT

findingsWith regards to changing epidemiology, autochthonous cases are being found within the USA in addition to Latin America. Additionally, there appears to be more intermixing of discrete typing units-meaning, they are not confined to specific geographic regions. Screening for Chagas disease is recommended in persons who lived in areas with endemic Chagas, persons wtih family member diagnosed with Chagas Disease, persons who have lived in homes of natural material in Latin America, and persons with history of kissing bug bites. Treatment for the parasitic infection remains limited to benznidazole and nifurtimox, and the role of these treatments in Chagas cardiomyopathy has not yet been definitively defined. Finally, indications for and management of heart transplant in the setting of Chagas disease are discussed. FUTURE RESEARCH: Use of antiparasitics during chronic chagas disease should be further explored. Additionally, future research identifying other markers of infection would be valuable to defining cure from infection.

Indexed as

Chagas DiseaseNitroimidazolesTrypanocidal AgentsTrypanosoma cruziAnimalsChagas CardiomyopathyHeart TransplantationHumansLatin AmericaNifurtimoxbenzonidazoleNifurtimoxNitroimidazolesTrypanocidal AgentsChagas Disease DiagnosisChagas Disease EpidemiologyChagas Disease ScreeningTrypanosoma Cruzi

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.